David R. Houck
Geen lopende functies
Profiel
Dr. David R.
Houck was previously employed as a SVP-Product Development & Portfolio Management by Assembly Biosciences, Inc., a Chief Development Officer by Aptinyx, Inc., a VP-Drug Development Operations & Quality by Naurex, Inc., a Chairman by Pharmakey LLC, a Principal by SCYNEXIS, Inc., a Principal by OSI Pharmaceuticals, Inc., a Principal by Merck & Co., Inc., and a Principal by Sterling Drug, Inc. He received his undergraduate degree from Alma College, a graduate degree from Purdue University and a doctorate degree from The Ohio State University.
Eerdere bekende functies van David R. Houck
| Bedrijven | Functie | Einde |
|---|---|---|
Pharmakey LLC
 Pharmakey LLC Pharmaceuticals: MajorHealth Technology Pharmakey LLC develops and manufactures pharmaceutical products. It offers pharmaceutical development and due diligence consulting, outsourcing and implementation, regulatory and quality and electronic regulatory publishing services. The company was founded by David R. Houck in January 2008 nd is headquartered in Durham, NC. | Algemeen Directeur | - |
| ASSEMBLY BIOSCIENCES, INC. | Corporate Officer/Principal | 01-10-2020 |
Naurex, Inc.
 Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Corporate Officer/Principal | 01-08-2015 |
| SCYNEXIS, INC. | Corporate Officer/Principal | 01-01-2006 |
| OSI PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-01-1998 |
Opleiding van David R. Houck
| Alma College | Undergraduate Degree |
| Purdue University | Graduate Degree |
| The Ohio State University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| SCYNEXIS, INC. | Health Technology |
| APTINYX | Health Technology |
| ASSEMBLY BIOSCIENCES, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
Naurex, Inc.
Naurex, Inc. Pharmaceuticals: MajorHealth Technology Naurex, Inc. operates as a clinical-stage company, which develops therapies. The firm offers therapies for depression and other disorders in the central nervous system based on a mechanism of action for modulating the NMDA receptor (NMDAR). It offers a line of chemical drug classes, such as glycine-site functional partial agonists, which modulate the receptor in a different way than existing NMDAR agents. The firm provides GLYX-13, an NRX-1050 small molecule series and additional compounds for treatment-resistant depression. The company was founded by Joseph R. Moskal in 2006 and is headquartered in Evanston, IL. | Health Technology |
Pharmakey LLC
Pharmakey LLC Pharmaceuticals: MajorHealth Technology Pharmakey LLC develops and manufactures pharmaceutical products. It offers pharmaceutical development and due diligence consulting, outsourcing and implementation, regulatory and quality and electronic regulatory publishing services. The company was founded by David R. Houck in January 2008 nd is headquartered in Durham, NC. | Health Technology |
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
| Sterling Drug, Inc. | Consumer Non-Durables |
